by Pinazo M-J, Malchiodi E, Ioset J-R, Bivona A, Gollob KJ, Dutra WO. The Lancet Microbe 2024, 100972. doi: 10.1016/j.lanmic.2024.100972
Summary: In order to develop effective vaccines and therapies against Chagas disease, it is essential to understand the intricate dynamics of parasite-host interactions and the resulting immune responses, which contribute to both protection and pathology. The authors of this Series paper discuss the challenges associated with discovering and translating prophylactic and therapeutic strategies from the laboratory bench to clinical application. They highlight ongoing efforts in vaccine and new drug development, with a focus on more advanced candidates for vaccines and drugs. They also discuss potential solutions, emphasising the importance of collaborative research efforts, sustained funding, and a comprehensive understanding of host-parasite interactions and immunopathology to advance the development of new vaccines and therapies against Chagas disease.
The post Challenges and advancements in the development of vaccines and therapies against Chagas disease first appeared on DNDi.
Hasta la fecha, hemos desarrollado nueve tratamientos para enfermedades desatendidas, salvando millones de vidas. Nuestro objetivo es poner a disposición 25 nuevos tratamientos en nuestros primeros 25 años. ¡Nos puedes ayudar!
Organización internacional sin fines de lucro que desarrolla tratamientos seguros, efectivos y asequibles para los pacientes más desatendidos.
A excepción de imágenes, películas y marcas comerciales que están sujetas a los Términos de uso de la DNDi, el contenido de este sitio tiene una licencia Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License.
© 2024 - DNDi América Latina